Short interest in Intellia Therapeutics Inc (NASDAQ:NTLA) decreased during the last reporting period, falling from 24.06M to 24.06M. This put 26.9% of the company's publicly available shares short.

Short interest for Intellia Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Intellia Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 2.94M shares traded per day, it would take 8.18 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.